Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher I Li

Showing results (101-110 of 276) with videos related to

Pageof 28
Sort By:
Hormones & Cancer|April 17, 2019
Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast CancerNicole C Lorona, Linda S Cook, Mei-Tzu C Tang, et al.
JNCI Cancer Spectrum|July 31, 2019
Relationship Between Anthropometric Factors and Risk of Second Breast Cancer Among Women With a History of Ductal Carcinoma In SituMeghan R Flanagan, Mei-Tzu C Tang, Michelle L Baglia, et al.
Cancer Research|February 29, 2012
Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of ageChristopher I Li, Elisabeth F Beaber, Mei Tzu Chen Tang, et al.
JAMA Internal Medicine|August 8, 2013
Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 yearsChristopher I Li, Janet R Daling, Mei-Tzu C Tang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 9, 2013
Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of ageJean A McDougall, Kathleen E Malone, Janet R Daling, et al.
Cancer|September 26, 2003
Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 yearsChristopher I Li, Kathleen E Malone, Noel S Weiss, et al.
Cancer Causes & Control : CCC|August 4, 2021
Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancerNicole C Lorona, Linda S Cook, Mei-Tzu C Tang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 17, 2016
Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic WomenLu Chen, Christopher I Li, Mei-Tzu C Tang, et al.
Annals of Surgical Oncology|July 1, 2022
Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast CancerMeghan R Flanagan, David R Doody, Jenna Voutsinas, et al.
JAMA Oncology|May 26, 2018
Breast Cancer With a Poor Prognosis Diagnosed After Screening Mammography With Negative ResultsAnne Marie McCarthy, William E Barlow, Emily F Conant, et al.
Pageof 28

Showing results (101-110 of 276) with videos related to

Sort By:
Pageof 28
Hormones & Cancer|April 17, 2019
Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast CancerNicole C Lorona, Linda S Cook, Mei-Tzu C Tang, et al.
JNCI Cancer Spectrum|July 31, 2019
Relationship Between Anthropometric Factors and Risk of Second Breast Cancer Among Women With a History of Ductal Carcinoma In SituMeghan R Flanagan, Mei-Tzu C Tang, Michelle L Baglia, et al.
Cancer Research|February 29, 2012
Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of ageChristopher I Li, Elisabeth F Beaber, Mei Tzu Chen Tang, et al.
JAMA Internal Medicine|August 8, 2013
Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 yearsChristopher I Li, Janet R Daling, Mei-Tzu C Tang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 9, 2013
Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of ageJean A McDougall, Kathleen E Malone, Janet R Daling, et al.
Cancer|September 26, 2003
Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 yearsChristopher I Li, Kathleen E Malone, Noel S Weiss, et al.
Cancer Causes & Control : CCC|August 4, 2021
Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancerNicole C Lorona, Linda S Cook, Mei-Tzu C Tang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 17, 2016
Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic WomenLu Chen, Christopher I Li, Mei-Tzu C Tang, et al.
Annals of Surgical Oncology|July 1, 2022
Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast CancerMeghan R Flanagan, David R Doody, Jenna Voutsinas, et al.
JAMA Oncology|May 26, 2018
Breast Cancer With a Poor Prognosis Diagnosed After Screening Mammography With Negative ResultsAnne Marie McCarthy, William E Barlow, Emily F Conant, et al.
Pageof 28